RxDoctor Payments Data

Bethanie Thibodaux

Primary Care · Morgan City, LANPI 1740732536

Payments from drug & device makers

$445in general payments, 2019–2025

Across 24 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$121
  • Exact Sciences$103
  • Lilly USA, LLC$72
  • Bayer$65
  • Astellas Pharma US Inc$37
  • Pfizer$26
  • plus $21 from 2 others

What the payments were for

  • Food & beverage$445100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$445 in reported general payments places this provider in the 40th percentile of 106 primary care providers in Louisiana.

See all primary care providers in Louisiana

Medicare billing

Part B allowed, 2024
$340
Medicare patients
16
Services billed
46

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide64$71,850
TrulicityDulaglutide35$60,219
OzempicSemaglutide49$48,989
JardianceEmpagliflozin31$45,962
UbrelvyUbrogepant13$24,293
LinzessLinaclotide23$20,281
MyrbetriqMirabegron17$15,251
Stiolto RespimatTiotropium Br/Olodaterol Hcl14$14,783
Breo ElliptaFluticasone/Vilanterol24$14,183
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog16$4,361
Lubiprostone17$2,622
Albuterol Sulfate HfaAlbuterol Sulfate103$2,250
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$1,397
Rosuvastatin Calcium81$864
Gabapentin87$763

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$72$132,06999 claims
Boehringer IngelheimJardiance, Stiolto Respimat$15$60,74545 claims
AbbVieUbrelvy, Linzess$121$44,57436 claims
Astellas Pharma US IncMyrbetriq$37$15,25117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 106 primary care providers in Louisiana.

Other primary care in Morgan City

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →